Let's dig a little bit deeper into these papers! 🪏

IgA nephropathy, also known as #BergersDisease, is a condition that affects both the #kidneys and the immune system. A clinical trial conducted by Dr. Sean Barbour and team found that the drug Felzartamab can significantly improve kidney function.

Graphic about NICE recommending a new treatment for primary IgA nephropathy (Berger's disease) to slow kidney damage, shared by Kidney Care UK. The image in the background shows someone holding a brown pill between their thumb and forefinger next to a pill box. There is a teal theme to the image. The Kidney Care UK logo is at the bottom right side.

1/3 📰 We are pleased to see the announcement from @nicecomms.bsky.social today about recommending medication #Sparsentan for treating primary IgA nephropathy (#IgAN), also known as #BergersDisease...

Making Noise About a Silent Disease Funded by the George and Angeliki Perlegos Charitable Trust, Richard Lafayette’s breakthrough research in kidney disease is advancing the understanding and treatment of IgA Nephropathy (IgAN).

IgA Nephropathy (#IgAN) is often a silent disease—until it's too late. #autoimmunekidneydisease #IgAN #Bergersdisease. medicine.stanford.edu/news/current...